These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20422595)

  • 1. Bluetongue vaccination in Europe: the Italian experience.
    Patta C; Giovannini A; Rolesu S; Nannini D; Savini G; Calistri P; Santucci U; Caporale V
    Vet Ital; 2004; 40(4):601-10. PubMed ID: 20422595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination in the control strategy of bluetongue in Italy.
    Caporale V; Giovannini A; Patta C; Calistri P; Nannini D; Santucci U
    Dev Biol (Basel); 2004; 119():113-27. PubMed ID: 15742623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bluetongue in Italy: Part II.
    Giovannini A; Calistri P; Nannini D; Paladini C; Santucci U; Patta C; Caporale V
    Vet Ital; 2004; 40(3):252-9. PubMed ID: 20419673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk analysis on the introduction into free territories of vaccinated animals from restricted zones.
    Giovannini A; Conte A; Calistri P; Di Francesco C; Caporale V
    Vet Ital; 2004; 40(4):697-702. PubMed ID: 20422617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bluetongue virus surveillance in a newly infected area.
    Giovannini A; Calistri P; Conte A; Savini L; Nannini D; Patta C; Santucci U; Caporale V
    Vet Ital; 2004; 40(3):188-97. PubMed ID: 20419661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Faes C; Abrahantes JC; Hendrickx G; Staubach C; Gerbier G; Elbers AR; Aerts M; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):145-61. PubMed ID: 18649960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.
    Monaco F; De Luca N; Spina P; Morelli D; Liberatore I; Citarella R; Conte A; Savini G
    Vet Ital; 2004; 40(4):657-60. PubMed ID: 20422606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vaccination against bluetongue on milk production and quality in cattle vaccinated with live-attenuated monovalent type 2 vaccine.
    Giovannini A; Conte A; Panichi G; Calistri P; Dessì M; Foddis F; Schintu A; Caporale V
    Vet Ital; 2004; 40(4):648-53. PubMed ID: 20422604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bluetongue: pathogenesis and duration of viraemia.
    MacLachlan NJ
    Vet Ital; 2004; 40(4):462-7. PubMed ID: 20422570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health management of large transhumant animal populations and risk of bluetongue spread to disease-free areas.
    Nannini D; Calistri P; Giovannini A; Di Ventura M; Cafiero MA; Ferrari G; Santucci U; Caporale V
    Vet Ital; 2004; 40(4):707-12. PubMed ID: 20422619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of bluetongue in Europe.
    Zientara S; Sánchez-Vizcaíno JM
    Vet Microbiol; 2013 Jul; 165(1-2):33-7. PubMed ID: 23462519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bivalent bluetongue virus serotypes 2 and 9 vaccine on reproductive performance of cattle: a case study in Calabria, Italy.
    Lucifora G; Rossi P; Calistri P; Giovannini A
    Vet Ital; 2004; 40(4):654-6. PubMed ID: 20422605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection of European red deer (Cervus elaphus) with bluetongue virus serotypes 1 and 8.
    López-Olvera JR; Falconi C; Férnandez-Pacheco P; Fernández-Pinero J; Sánchez MA; Palma A; Herruzo I; Vicente J; Jiménez-Clavero MA; Arias M; Sánchez-Vizcaíno JM; Gortázar C
    Vet Microbiol; 2010 Sep; 145(1-2):148-52. PubMed ID: 20395075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental bluetongue virus infection of sheep; effect of previous vaccination: clinical and immunologic studies.
    Mahrt CR; Osburn BI
    Am J Vet Res; 1986 Jun; 47(6):1191-7. PubMed ID: 3014926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.